Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults

Exclusion Criteria

• •History of serious disease.
• •History of serious reaction following administration of vaccine or hypersensitivity to vaccine components.
• •Known or suspected impairment/alteration of immune function.
• •Receipt or planned receipt of seasonal trivalent influenza vaccine within 1 week before or after each study vaccination.
• •Sexually active women of childbearing potential must use acceptable birth control during the treatment phase of the study.
• •For additional entry criteria, please refer to protocol.